← Eichor
Study identifier: NCT05345821 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants With Smooth Surface

Condition: Breast Implant; Complications · Quality of Life · Satisfaction  ·  Sponsor: Silimed Industria de Implantes Ltda

PhaseN/A
Planned participants384
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersYes

About this study

The study investigates the safety and performance of Silimed® brand smooth surface breast implants in women born with indication for primary and secondary (revision) augmentation to be followed up for 10 years. The safety of the smooth-surfaced Silimed® implant will be evaluated by estimating known and unexpected short-term and long-term risk/adverse event rates through patient reports of adverse events after implantation. The performance of using Silimed® brand smooth surface breast implants will be evaluated by evaluating satisfaction and quality of life after implantation.

This description comes directly from the study's public registry record.

Talk to the study team

Ludmila C Donato  ·  +552198399-0573  ·  Pesquisaclinica@silimed.com.br

Julia Maria V Roberto  ·  +55212784 - 2772  ·  pesquisa.clinica@silimed.com.br

Always discuss trial participation with your own doctor first.

Locations (1)

Fundação do ABC - Centro universitário FMABCSanto André, São Paulo, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05345821